GluSense For Profit

GluSense is developing a miniature implantable continuous glucose sensor. The sensor will be implanted under the skin and will transmit continuous glucose values to an external unit or smartphone for over a full year, significantly improving the quality of life of diabetes patients. Founded in 2007, the company is part of the rainbow medical innovation house.


Investors

Funding Status: N/A
Headquarters: Lod, HaMerkaz, Israel
Founded Date: 2007-01-01
Investor Type: N/A
Investment Stage: N/A
Technology: Biomarker panels
Employee Number: 10-50
Number Of Exists: N/A
Industry: Clinical Data Management